Introduction
aberrant centrioles is consistent with the presence of only singlet microtubules. Indeed, 108
only singlet microtubules were identified in the two cross-sections observed, from 109 TUBD1 -/-cells ( Figure 1C ). These results demonstrate that cells lacking either delta-110 tubulin or epsilon-tubulin form defective centrioles that lack normal triplet microtubules. 111
This is similar to the defects reported for delta-tubulin and epsilon-tubulin mutants in 112 unicellular eukaryotes. 113 114
Centrioles in both tubulin mutants were also shorter than typical, mature centrioles: 230 115 nm +/-45 nm in in TUBD1 -/-cells (n = 14 centrioles), and 271 nm +/-43 nm in in TUBE1 116 -/-cells (n = 11 centrioles), compared to approximately 500 nm for typical human cell 117
centrioles (Paintrand et al., 1992) . Newly-formed mammalian centrioles, or 118 procentrioles, reach their full length by elongation in G2-M, creating a distal 119 compartment that is a feature of centrioles in some, but not all, organisms. We sought to 120 determine whether the aberrant centrioles in TUBD1 -/-and TUBE1 -/-cells are 121 capable of elongation and formation of the distal compartment. We analyzed the 122 ultrastructure of centrioles in a TUBE1 -/-prometaphase cell using correlative light-123 electron microscopy ( Fig. 2A ). These aberrant centrioles (n = 3) exhibited a striking 124 morphological phenotype, consisting of two electron-dense segments, one of ~50 nm 125 and the other of ~200 nm, connected by singlet microtubules spanning a gap of ~250 126 nm. The total length (~500 nm) of these structures approximates that of typical mature 127 mammalian centrioles. 128 129
We hypothesized that the aberrant centrioles formed in TUBD1 -/-and TUBE1 -/-cells 130 elongate in G2-M, but that only the A-tubule is present and thus able to elongate as a 131
singlet. In this model, the shorter, distal density might correspond to the CP110 cap, 132
under which the centriolar microtubules elongate (Kleylein-Sohn et al., 2007) . The 133 longer, 200 nm density corresponds to the proximal centriole end containing the 134 cartwheel, as observed above in interphase cells. A prediction of this model is that the 135 distance between CP110 and the SASS6 fluorescent labels would increase by about 136
200 nm in mitosis. We found that in TUBD1 -/-and TUBE1 -/-interphase cells, similar to 137 control TP53 -/-cells, the centroids of CP110 and SASS6 foci were separated by a 138 mean distance of 0.3 µm, whereas in mitotic cells the foci were separated by a mean 139 distance of 0.5 µm ( Fig 2B and 2C) . Thus, centrioles in TUBD1 -/-and TUBE1 -/-cells 140 elongate at the appropriate time in the cell cycle, and have a cap and proximal end 141 typical of newly-formed centrioles. The lack of electron-dense structure between the 142 cartwheel and cap might be due to a failure to recruit distal compartment components. 143
Consistent with this, we found that the distal compartment component POC5 is absent 144 from these aberrant centrioles ( Fig 2D) .
146
Together, these results indicate that the primary centriolar defect in cells lacking delta-147 tubulin or epsilon-tubulin is the absence of triplet microtubules . To determine the  148  consequences of loss of triplet microtubules on the centriole cycle and centrosome  149 formation, we first determined the distribution of centrioles in asynchronously dividing 150 cell populations, as determined by staining for the established centriole proteins centrin 151 and CP110. TP53 -/-control cells had a typical centriole number distribution, with 152 approximately 50% of cells having two centrioles, corresponding to cells in G1 phase, 153
and 40% having three to four centrioles, corresponding to cells in S through M phases.
154
In contrast, in TUBD1 -/-and TUBE1 -/-cells, approximately 50% of cells had 5 or more 155 centriole foci, whereas 50% of cells had no detectable foci positive for both centrin and 156 CP110 ( Fig. 3A and 3B ). Similar centriole distributions were found in other, 157
independently derived, TUBD1 -/-and TUBE1 -/-cell lines. In addition, this phenotype 158 could be rescued by expression of delta-tubulin and epsilon-tubulin, respectively (Fig 3  159 -supplement 1A -1C).
161
We reasoned that a possible explanation for the centriole distribution in TUBD1 -/-and 162 TUBE1 -/-cells is that the centriole structures we observed by EM are produced de 163 novo in each cell cycle, and that these aberrant centrioles are unstable and do not 164
persist into the next cell cycle. This hypothesis predicts that the aberrant centrioles in 165 TUBD1 -/-and TUBE1 -/-cells would 1) not be paired, since de novo centrioles only 166 form in the absence of an existing centriole, 2) lack markers of maturation such as distal 167 appendages, since they would not persist to the point of acquiring such proteins, 3) fail 168
to recruit substantial pericentriolar material, since the centriole-centrosome conversion 169 occurs at entry to the next cell cycle, and 4) would be formed in S phase, and be lost at 170 some point prior to the subsequent S phase. 171 172
In agreement with this hypothesis, the centrioles, as visualized by centrin and CP110 173
were never observed to be closely apposed, as is typical of wild-type cells (Fig. 3A ).
174
Rather, in interphase they appeared to be distributed within the central region of the cell 175 (Fig. 3A) . The centrioles in asynchronous TUBD1 -/-and TUBE1 -/-cells all lacked 176
Cep164, a component of the centriolar distal appendage and marker of mature 177 centrioles that have progressed through at least one cell cycle ( Fig. 3C ), whereas 178 approximately 40% of all centrioles were positive for Cep164 in asynchronous control 179 cells, consistent with the cycle of distal appendage acquisition (Nigg and Stearns, 180 2011) . Lastly, most of the centrioles in TUBD1 -/-and TUBE1 -/-cells lacked 181 detectable gamma-tubulin ( Fig. 3C ), and those that stained positive had less than 182 centrioles in control cells (Fig 3 -supplement 1D ). In addition, we noted that SASS6, 183
the cartwheel protein that is present in nascent and recently-formed centrioles, but is 184 lost from centrioles at the mitosis-interphase transition in human cells, was present in 185 most of the centrioles in TUBD1 -/-and TUBE1 -/-cells, consistent with these centrioles 186 originating in the observed cell cycle, but not having successfully persisted into the 187 subsequent cell cycle. 188 189
To investigate the fate of newly-formed centrioles in TUBD1 -/-and TUBE1 -/-cells, we 190
next tested the cell cycle-dependence of the formation and loss of aberrant centrioles in 191 TUBD1 -/-and TUBE1 -/-cells ( Fig 4A) . As in previous experiments, about 50% of 192 TUBD1 -/-and TUBE1 -/-cells in an asynchronous population had centrin and positive foci corresponding to aberrant centrioles. TUBD1 -/-and TUBE1 -/-cells were 194
analyzed in different cell cycle stages as follows: G0/G1 -synchronized by serum 195
withdrawal, S phase -identified from asynchronous culture by PCNA labeling, G2 -196 synchronized by the CDK1 inhibitor RO-3306, and M -identified from asynchronous 197 culture by presence of condensed chromatin (Fig. 4A ). TUBD1 -/-and TUBE1 -/-cells 198 in G0/G1 mostly lacked centriole structures, whereas cells in S-phase, G2 and mitosis 199 had them. These results indicate that in TUBD1 -/-and TUBE1 -/-cells, aberrant 200
centrioles are formed in S-phase, persist into mitosis, and are absent in G1. We note 201 that this loss of centriole structure is likely due to a specific event that occurs at the 202 mitosis-interphase transition, rather than simply time since formation, since cells were 203 arrested in G2 for 24 h, which is substantially longer than the normal progression 204 through mitosis to G1, yet the centriole structures persisted ( Fig 4A) . 205 206
To more finely determine the timing of centriole loss in the mitosis-interphase transition, 207 control or TUBE1 -/-cells were synchronized by mitotic shakeoff, and the presence of 208 centriole foci was assessed over time as cells entered G1 ( Fig 4B) . In control cells, the 209 number of centrioles follows the pattern expected from the centriole duplication cycle. In 210 TUBE1 -/-cells, the majority of mitotic cells had centrioles. By 1 h after shakeoff, the 211 fraction of interphase cells without centrioles had increased to 50%, and this fraction 212 continued to increase at 2 h and 3 h after shakeoff. By 12 h after shakeoff, 56 +/-12% of 213 cells had entered S-phase, and centriole structures began to appear, consistent with de 214 novo centriole formation. Thus, delta-tubulin and epsilon-tubulin are not required to 215 initiate centriole formation in human cells, but the aberrant centrioles that form in their 216
absence are unstable and disintegrate during progression from M phase to the 217 subsequent G1 phase. 218 219
Centrioles formed de novo can persist to form fully mature centrioles (Lambrus et al., 220 2015; Wong et al., 2015) , but have also been reported to be structurally defective 221 (Wang et al., 2015) . We tested whether the phenotype we observed is specific to loss of 222 delta-tubulin and epsilon-tubulin, rather than a property of de novo centrioles in general, 223 by assessing whether de novo centrioles formed in the presence of delta-tubulin and 224 epsilon-tubulin would also disintegrate upon cell cycle progression. RPE-1 TP53 -/-cells 225
were treated with centrinone to inhibit PLK4 (Wong et al., 2015), a kinase required for 226 centriole duplication, for more than 2 weeks to obtain acentriolar cells. Centrinone was 227 then washed out from mitotic cells; by 12 h after shakeoff, 36% of cells had entered S-228 phase, and centriole structures began to appear, consistent with de novo centriole 229
formation. However, in contrast to TUBD1 -/-and TUBE1 -/-cells, these de novo 230
centrioles persisted through the subsequent G1 ( Fig 4C) . We conclude that centriole 231 instability in TUBD1 -/-and TUBE1 -/-cells is due to a specific defect in their structure, 232
and is not a general feature of de novo centrioles, similar to previous reports (La Terra 233 et al., 2005) . 234 235
We hypothesized that centriole disintegration may result from instability of the centriolar 236 microtubules, perhaps as a result of elongation in G2-M phase. To test this, 237
microtubules were stabilized in G2-M stage TUBE1 -/-cells by addition of the 238 microtubule-stabilizing drug paclitaxel. This treatment did not inhibit centriole elongation 239
( Fig 4 -supplement 1B ). Cells were allowed to enter mitosis in the presence of 240 paclitaxel, and subsequently forced out of mitosis using the CDK inhibitor This treatment was sufficient to stabilize centrioles from mutant cells in G1, compared 242
with cells that had not been treated with paclitaxel ( Fig 4D and Fig 4 -supplement 1 ). 243
These stabilized centrioles lose their SASS6 cartwheel and fail to recruit detectable 244 gamma-tubulin ( Fig 4 -supplement 1 ). We conclude that stabilization of the centriolar 245 microtubules in TUBE1 -/-cells stabilizes the centriole structure. 246 247
One striking observation of this work is that the phenotypes of delta-tubulin and epsilon-248 tubulin null mutants are similar. This strongly suggests that the proteins work together to 249 accomplish their function. To test this hypothesis, we assessed the ability of delta-250 tubulin and epsilon-tubulin to interact by co-expression in human HEK293T cells. 251
Epsilon-tubulin could be immunoprecipitated with delta-tubulin from co-expressing cells, 252
and not from control cells ( Fig 5A) . 253 254
Together, our results show that delta-tubulin and epsilon-tubulin act together to create 255 or stabilize structural features of centrioles. The most obvious such feature is the triplet 256 microtubules, which define centrioles in most species, and are absent in delta-tubulin or 257 epsilon-tubulin mutant cells in all organisms which have been examined. This suggests 258 that delta-tubulin and epsilon-tubulin are required either to form the triplet microtubules, 259
or to stabilize them against depolymerization. The former seems unlikely, since the 260 presence of triplet centriolar microtubules is not strictly correlated with the presence of 261 delta-tubulin and epsilon-tubulin in evolution ( Fig 5B and Fig 5 - Supplemental Table 1 ). 262
Among the organisms that completely lack the ZED tubulin module, C. elegans lacks 263 triplet microtubules, but both Drosophila and the primitive plant Ginkgo biloba have 264 triplet microtubules in their sperm cells. Since loss of the entire ZED tubulin module 265 must have occurred independently in the dipteran insect and plant lineages, the most 266 parsimonious interpretation is that triplet microtubule formation itself does not require 267 delta-tubulin or epsilon-tubulin, rather than that these two lineages independently 268 evolved mechanisms of triplet formation in their absence. Thus, we propose that delta-269 tubulin and epsilon-tubulin are required for stabilization of the centriolar triplets in most 270 organisms, such that the centrioles can mature and recruit other proteins. We do not yet 271
know the molecular basis of this differential requirement for delta-tubulin or epsilon-272 tubulins with respect to microtubule triplet stability. However, we note that the few 273
centriole-bearing organisms that lack delta-tubulin and epsilon-tubulin have simpler 274 centriole structures that lack distal appendages, and, to the extent it is possible to tell, 275 lack a distal compartment that is typical of more complex centrioles.
277
Why do centrioles disintegrate in delta-tubulin and epsilon-tubulin mutant cells? We 278 have shown that in TUBD1 -/-and TUBE1 -/-cells, aberrant centrioles with elongated 279 singlet microtubules connecting the proximal and distal centriole segments become 280 unstable as cells progress through mitosis. This is remarkably similar to the progressive 281 loss of centrioles described in the original characterization of the epsilon-tubulin mutant 282 bald-2 by Goodenough and St. Clair (Goodenough and StClair, 1975) . In human cells, 283
Izquierdo, et al. reported that centrioles in CEP295 -/-human cells also become 284 unstable upon cell cycle progression, due to a failure of centrioles to recruit 285 pericentriolar material that coincides with loss of the cartwheel during the centriole-to-286 centrosome conversion at the end of mitosis (Izquierdo et al., 2014) . Although the 287 phenotypes are outwardly similar to the phenotypes we describe here, CEP295 is 288 conserved in species lacking delta-tubulin and epsilon-tubulin (Fu et al., 2015) , and 289 centrioles in Chlamydomonas do not undergo centriole-to-centrosome conversion. We 290
propose that the post-duplication centriole elongation that creates the distal 291 compartment of the centriole is a critical time in centriole stability, and that the triplet 292 microtubules, either directly or through proteins that associate with them, are required to 293 prevent centriole disassembly subsequent to that step. One possible basis for the 294 instability is that events at the distal end of the centriole associated with preparing it to 295 serve as a basal body for a cilium in G1 expose the ends of the centriolar microtubules.
296
The doublet microtubules normally present at the end would be resistant to 297 depolymerization in this model, but the singlets found in delta-tubulin and epsilon-tubulin 298 mutants might be unstable. In accordance with this possibility, stabilization of centriolar 299 microtubules with paclitaxel was able to prevent centriole disintegration, even when 300 both the SASS6 cartwheel and pericentriolar material are lost ( Fig 4D and Fig 4 -301 supplement 1). Another possibility is that centrioles lacking the normal triplet structure 302 would likely also lack the A-C linker, which is visible in EM as a bridge between the A-303
and C-tubules of adjoining triplets. Perhaps the A-C linker is most important for stability 304
after the full elongation of the centriolar microtubules. No components of the A-C linker 305 have been identified, but the poc1 mutant in Tetrahymena causes partial loss of this 306 linker and results in instability of triplet microtubules (Meehl et al., 2016) . 307 308
Here we have shown that delta-tubulin and epsilon-tubulin likely work together in a 309
critical function for centriole structure and function, and that cells lacking delta-tubulin or 310 epsilon-tubulin undergo a futile cycle of de novo centriole formation and disintegration. 311
Our results show that in human cells, delta-tubulin and epsilon-tubulin act to stabilize 312 centriole structures necessary for inheritance of centrioles from one cell cycle to the 313 next, perhaps by stabilizing the main structural feature of centrioles, the triplet 314 microtubules. 315 TP53 -/-cells were treated with centrinone for at least 2 weeks, then centrinone was 417
washed out from mitotic cells. Cells were analyzed in S-phase, 12 hours after washout 418 when 36% of cells had entered S-phase, and in the following G1 after mitotic shakeoff. 419
Bars represent the mean of three independent experiments with ≥100 cells each, error 420 bars represent the SEM. D) Paclitaxel rescues centriole disintegration phenotype. 421 TUBE1 -/-cells were either treated with paclitaxel or DMSO for 3 h in G2. Mitotic cells 422 from both populations were harvested by mitotic shakeoff, and forced out of mitosis with 423 RO-3306 for 3 h. Cells with micronuclei were analyzed for both conditions, and the 424 percent of cells with indicated numbers of centrin/CP110-positive centrioles are shown. 425
Bars represent the mean of three independent experiments with ≥100 cells each, error 426 bars represent the SEM. TUBE1 -/-cell line 2 was generated using lentiCRISPRv2 with the sgRNA sequence 496
GCGCACCACCATGACCCAGT. Transduction and selection were carried out as for 497
TUBD1 -/-cell lines. 498 499
Both rescue construct transfer vectors contained opposite orientation promoters: EF-500 1alpha promoter driving monomeric Kusabira Orange kappa (mKOk) with rabbit beta-501 globin 3'UTR, as well as mouse PGK promoter driving the rescue construct with WPRE. 502
For the delta-tubulin rescue construct, silent mutations were made in the PAM and 503
surrounding sequence such that it was no longer complementary to the lentiCRISPR 504 sgRNA (C117G and A120T) using QuikChange Lightning Site-Directed Mutagenesis Kit 505
(Agilent). For the epsilon-tubulin rescue construct, full-length TUBE1 cDNA was used. 506
Using these transfer vectors, lentivirus was produced and TUBD1 -/-and TUBE1 -/-507 cells, respectively, were transduced. For rescue experiments, cells expressing mKOk 508
were counted. 509 510
Correlative light and electron microscopy 511
Correlative light and electron microscopy (CLEM) was performed as described 512
previously (Kong and Loncarek, 2015) , using hTERT RPE-1 TP53 -/-TUBD1 -/-and 513
TP53 -/-TUBE1 -/-GFP-centrin cells. Cells in Rose chambers were enclosed in an 514 environmental chamber at 37 °C and imaged on an inverted microscope (Eclipse Ti; 515
Nikon, Tokyo, Japan) equipped with a spinning-disk confocal head (CSUX Spinning 516
Disk; Yokogawa Electric Corporation, Tokyo, Japan). After analysis by live imaging, 517
Rose chambers were perfused with freshly prepared 2.5% glutaraldehyde, and 200-nm 518 thick Z-sections spanning the entire cell were recorded to register the position of 519 centrioles. Cell positions on coverslips were then marked by diamond scribe. Rose 520 chambers were disassembled, and cells were washed in PBS, followed by staining with 521 2% osmium tetroxide and 1% uranyl acetate. Samples were dehydrated and embedded 522
in Embed 812 resin. The same cells identified by light microscopy were then serially 523
sectioned. For cell cycle analyses, TUBD1 -/-or TUBE1 -/-cells were seeded onto coverslips, then 552 synchronized in G0/G1 by serum withdrawal for 24 h, or in G2 with 10 µM RO-3306 for 553 24 h. Cells were fixed for immunofluorescence and analyzed for centrin/CP110 554 presence. Mitotic shakeoff was performed on asynchronously growing cells. One pre-555
shake was performed to improve synchronization. Cells were fixed at indicated times 556
and analyzed for centrin/CP110 presence. For centrinone experiments, hTERT RPE-1 557
p53 -/-cells were treated with 125 nM centrinone for ≥ 2 weeks, and centrinone-558
containing medium was replaced on top of cells daily. For centrinone washout, cells 559
were washed twice with PBS, then mitotic shakeoff was performed with centrinone-free 560 medium. A subset of cells were fixed for immunofluorescence 12 h after shakeoff, when 561 cells had entered S-phase. 19 h after shakeoff, a second shakeoff was performed to 562 harvest cells that entered mitosis. Cells were fixed 3 h post-second shakeoff for 563 immunofluorescence, and analyzed for centrin/CP110 presence. For paclitaxel 564 experiments, mitotic cells were removed by shakeoff from an asynchronous population, 565 then 15 µM paclitaxel or DMSO was added to the cells remaining on the dish. For both 566 populations, G2-phase cells were allowed to enter mitosis, and then harvested in 567 mitosis by shakeoff 3 h later. Cells were plated on coverslips and forced to exit mitosis 568 by treatment with 10 µM RO-3306, then fixed for immunofluorescence 3 h later. Cells 569 with micronuclei were analyzed for centrin/CP110 presence in both conditions. 570 571
Immunoprecipitation 572
HEK293T cells were co-transfected with GFP-delta-tubulin and myc-epsilon-tubulin, or 573 GFP and myc-epsilon-tubulin using PEI. 48 hours after transfection, cells were 574 harvested and lysed in lysis buffer (50 mM Hepes pH7.4, 150 mM NaCl, 1 mM DTT, 1 575 mM EGTA, 1 mM MgCl2, 0.25 mM GTP, 0.5% Triton X-100, 1 µg/ml each leupeptin, 576 pepstatin, and chymostatin, and 1 mM phenylmethylsulfonyl fluoride). Insoluble material 577 was pelleted, and soluble material was incubated at 4 °C with GFP-binding protein 578 (Rothbauer et al., 2008) coupled to NHS-activated Sepharose 4 Fast Flow resin (GE 579
Healthcare) for 2 h. Beads were pelleted at 500 g for 1 min, washed three times with 580 lysis buffer, then eluted in sample buffer and the eluate was run on SDS-PAGE gels. 581
Western blots were scanned on a LiCOR imager and analyzed using ImageJ. 582 583 584
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